Alto Pharmacy Holdings, Inc. — Cyborg Score 8/10

Strong
Digital pharmacy and medication delivery

Strategic Profile

Alto has solidified its position as the leader in disrupting the $500 billion retail pharmacy industry, with revenue over $700 million annual run rate, up more than 100% in the last 12 months. The company expanded coverage to more than 36 million people by launching its full-service telehealth pharmacy service in New York, Dallas, and Houston, and expanding in San Jose.

Cyborg Score Rationale

Alto achieved over $700 million annual run rate with 100%+ year-over-year revenue growth and raised a $200 million Series E led by SoftBank Vision Fund. The company demonstrates market leadership in digital pharmacy but remains private and operates in a capital-intensive, highly regulated segment with intense competition.

Top Insights

  • Alto achieved $700 million+ annual run rate with 100%+ year-over-year growth, demonstrating strong market demand for digital pharmacy services and validating the business model's ability to scale profitably.
  • In the prior year, Alto raised $250 million and expanded into Las Vegas, Seattle, and Denver while offering enhanced expertise in complex therapeutic areas including diabetes, heart and lung health, fertility, and HIV care.
  • Alto was acquired by Fuze Health on March 21, 2025, which may accelerate integration with other healthcare platforms and expand customer acquisition and distribution channels.

Named Competitors

  • PillPack — Pharmacy-by-mail with convenient packaging and delivery
  • Truepill — Digital pharmacy platform for prescription delivery
  • Capsule — Same-day prescription delivery service
  • GoodRx — Digital prescription discount and price comparison platform
  • Instacart Pharmacy — Pharmacy delivery integrated with grocery delivery platform
  • NowRx — Digital pharmacy with medication delivery and health insights

Recent Developments

  • (March 2025) Acquired by Fuze Health
  • (January 2022) Raised $200 million Series E round led by SoftBank Vision Fund
  • (2024-2025) Expanded into Las Vegas, Seattle, Denver, New York, Dallas, Houston

Open the full interactive Alto Pharmacy Holdings, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →